Physio-Control, Inc., a totally owned supplementary of Medtronic, Inc., (NYSE: MDT) declared today that it has conventional clearance by the U.S. Food and Drug Administration (FDA) to mart the LIFEPAK 20e defibrillator/monitor within the United States. The 20e is an improvement of the LIFEPAK 20 defibrillator/monitor, which has embellish the accepted of tending in some hospitals worldwide since its launching in 2002.

Tags: Hospital, Subsidiary, United States